ADAGE CAPITAL PARTNERS GP, L.L.C.

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 1165408 Boston, MA

Position in DNTH

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$13,427,200

+$10,397,250 QoQ

Shares Held

160,000

+107.8% QoQ

Ownership

0.293%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,593,636,445 across 120 Biotechnology names. DNTH ranks #58 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	5,475,611	$532,503,169
2	RPRX	Royalty Pharma plc	7,480,633	$358,845,965
3	CNTA	Centessa Pharmaceuticals plc	8,925,010	$354,501,397
4	ROIV	Roivant Sciences Ltd.	12,794,097	$354,396,486
5	TNGX	Tango Therapeutics, Inc.	12,809,485	$267,974,426
6	PRAX	Praxis Precision Medicines, Inc.	815,739	$262,822,948
7	INSM	INSMED Inc	900,000	$147,168,000
8	AXSM	Axsome Therapeutics, Inc.	737,578	$124,665,433

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$13,427,200	160,000	+107.8%	Shares	Sole	2026-05-15
2025-09-30	$3,029,950	77,000	-58.4%	Shares	Sole	2025-11-14
2025-06-30	$3,446,550	185,000	-2.1%	Shares	Sole	2025-08-14
2025-03-31	$3,428,460	189,000	+5.0%	Shares	Sole	2025-05-15
2024-12-31	$3,924,000	180,000	-28.0%	Shares	Sole	2025-02-14
2024-06-30	$6,470,000	250,000	-16.1%	Shares	Sole	2024-08-14
2024-03-31	$8,940,000	298,000	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.